Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

3.44
Delayed Data
As of Sep 23
 -0.01 / -0.29%
Today’s Change
1.88
Today|||52-Week Range
4.06
+13.53%
Year-to-Date
Why Rigel Pharmaceuticals' Stock Soared in August
Sep 14 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close3.45
Today’s open3.46
Day’s range3.39 - 3.50
Volume598,726
Average volume (3 months)1,487,359
Market cap$325.4M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+44.23%
Earnings growth (this year)-33.02%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+250.24%
P/E ratioNM
Price/Sales9.27
Price/Book3.41

Competitors

 Today’s
change
Today’s
% change
CRISCuris Inc-0.05-1.98%
EDGEEdge Therapeutics In...-0.24-2.12%
BOLDAudentes Therapeutic...-0.26-1.64%
SYRSSyros Pharmaceutical...-0.01-0.08%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$28.9M
Annual profit (last year)-$51.5M
Net profit margin-178.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Raul R. Rodriguez
CFO, Executive VP &
Head-Investor Relations
Ryan D. Maynard
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs